Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer
Cellular Oncology · 2024
DOI: 10.1007/s13402-023-00852-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Peng-Cheng Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, 201800, P.R.…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Jiading District Medical Key Discipline Foundation of Shanghai.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, 201800, P.R. China.
- State Key Laboratory of Oncogenes and Related Genes, Ren Ji Hospital, School of Medicine, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China.
- Department of General Surgery, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, 201800, P.R. China. shipeidong9410@163.com.
- Department of General Surgery, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, 201800, P.R. China. grs982600@163.com.
Förderung
- Jiading District Medical Key Discipline Foundation of Shanghai
Zitieren
APA
Chen, P. C., Ning, Y., Li, H., Su, J. G., Shen, J. B., Feng, Q. C., Jiang, S. H., Shi, P. D., & Guo, R. S. (2024). Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer. Cellular Oncology. https://doi.org/10.1007/s13402-023-00852-3
Vancouver
Chen PC, Ning Y, Li H, Su JG, Shen JB, Feng QC, et al. Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer. Cellular Oncology. 2024. doi:10.1007/s13402-023-00852-3
BibTeX
@article{Chen2024,
author = {Chen, Peng-Cheng and Ning, Yong and Li, Hui and Su, Jin-Gen and Shen, Jiang-Bo and Feng, Qing-Chun and Jiang, Shu-Heng and Shi, Pei-Dong and Guo, Run-Sheng},
title = {Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer},
journal = {Cellular Oncology},
year = {2024},
doi = {10.1007/s13402-023-00852-3}
}
EUVIMED